** Neoleukin Therapeutics 股价盘前下跌1.3%至69美分
** 该公司表示,将对其普通股进行 (link) 反向拆股,拆股比例为 1 比 5
** 股票分割将于9月25日生效
** 称股票分割是 NLTX 重新达到纳斯达克最低收购价要求计划的一部分
** 截至上次收盘,股价累计上涨 37.3
** Neoleukin Therapeutics 股价盘前下跌1.3%至69美分
** 该公司表示,将对其普通股进行 (link) 反向拆股,拆股比例为 1 比 5
** 股票分割将于9月25日生效
** 称股票分割是 NLTX 重新达到纳斯达克最低收购价要求计划的一部分
** 截至上次收盘,股价累计上涨 37.3
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.